Practitioner Notices

Undoubtedly it was a ghastly expensive 4 year ride, but on November 19, 2012, judges of the Texas State Office of Administrative Hearings dismissed the Texas Medical Board’s pending case against Dr. Burzynski.

The investigation started by the board in 2008 involved Burzynski’s novel off-label use of combination gene targeted therapy. Early on, two medical board informal settlement panels found that the use of these combination drugs on the advanced cancer patients involved was within the standard of care. However, the Texas Medical Board refused to drop the case and instead filed a formal complaint against Dr. Burzynski alleging the same standard of care violations previously rejected by the board settlement panels. After two years of intense litigation, the case was set for trial in April 2012. However, a week before trial, the administrative law judges dismissed most of the charges against Dr. Burzynski which forced the Board to seek to adjourn the case to do some reevaluation. After the judges denied the Board’s attempt to reverse the previous partial dismissal of the case, the Board did more reevaluation and moved to dismiss the entire case. We didn’t oppose the motion and on November 19, 2012, the case was dismissed.

Here is a copy of the dismissal

Earn $25 off your annual PMA license renewal fee
for each practitioner your introduce to the PMA!

It's simple, just introduce a friend or associate to PMA Commission and license and we will track your referral. If your friend completes PMA commission or license, we will apply a $25 credit to your PMA account.  Do this enough times and your next annual renewal can be FREE! Simply send your associates here to register and complete the brief online evaluation form.

To get started intoducing your friends and associates to the PMA just copy this link and send it with a note about PMA license!